Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ganea

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|May 12, 2001
Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAPD Ganea, M Delgado
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3M Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expressionM Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivoM Delgado, D Ganea
Archives of Physiology and Biochemistry|April 6, 2002
VIP and PACAP enhance the in vivo generation of memory TH2 cells by inhibiting peripheral deletion of antigen-specific effectorsM Delgado, D Ganea
Journal of Neuroimmunology|October 12, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophagesM Delgado, D Ganea
The Journal of Biological Chemistry|October 13, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1M Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?M Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6P Rameshwar, D Ganea, P Gascón
Blood|January 15, 1993
In vitro stimulatory effect of substance P on hematopoiesisP Rameshwar, D Ganea, P Gascón
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Archivum Immunologiae Et Therapiae Experimentalis|May 12, 2001
Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAPD Ganea, M Delgado
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3M Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expressionM Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|July 7, 2001
Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivoM Delgado, D Ganea
Archives of Physiology and Biochemistry|April 6, 2002
VIP and PACAP enhance the in vivo generation of memory TH2 cells by inhibiting peripheral deletion of antigen-specific effectorsM Delgado, D Ganea
Journal of Neuroimmunology|October 12, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophagesM Delgado, D Ganea
The Journal of Biological Chemistry|October 13, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1M Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?M Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6P Rameshwar, D Ganea, P Gascón
Blood|January 15, 1993
In vitro stimulatory effect of substance P on hematopoiesisP Rameshwar, D Ganea, P Gascón
Pageof 8